Metastatic Melanoma: Incorporating Lymphocyte-Activation Gene 3 Inhibitors Into the Treatment Paradigm

Nursing and Pharmacy Perspectives: Strategies for Optimizing the Care of Patients With Metastatic Melanoma: Are you up to date on treating patients with advanced melanoma with the latest checkpoint inhibitor combination lymphocyte activating gene 3 (LAG3)/programmed cell death protein 1 (PD-1)? Credit available for this activity expires: 5/30/24 Earn Credit... by Keeping Current CME

19 min listen

Ultrafast, Abbreviated, and Conventional Breast MRI: Who and Why?: Are you using abbreviated magnetic resonance imaging (MRI) protocols effectively for breast cancer screening? Credit available for this activity expires: 6/16/24 Earn Credit / Learning Objectives & Disclosures:... by Keeping Current CME

31 min listen

Evolving Landscape of HR-Positive Metastatic Breast Cancer: A Year in Review: Join the experts for an in-depth update on hormone receptor (HR)-positive metastatic breast cancer (MBC). Credit available for this activity expires: 3/1/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

76 min listen

Evolution of the Care of Patients With Advanced Ovarian Cancer: Do you know the best way to manage your patients with newly diagnosed advanced ovarian cancer? Credit available for this activity expires: 4/23/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

32 min listen

Multiparametric MRI for Active Surveillance of Prostate Cancer: How are you managing your prostate cancer patients on active surveillance? Credit available for this activity expires: 5/25/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

31 min listen

Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases: What is the clinical use of biosimilars and how to best communicate with patients to avoid the nocebo effect? Credit available for this activity expires: 3/29/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

35 min listen

Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations: Are you aware that molecular testing is necessary to inform the appropriate adjuvant treatment decision for patients? Credit available for this activity expires: 3/22/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

38 min listen

Immunotherapy in Special Populations With Non-Small Cell Lung Cancer: What Would the Oncologist Do?: Do you know the best way to administer immunotherapy in unique patients with non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 10/27/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

55 min listen

Advances in Topical Treatments for Seborrheic Dermatitis: Are you up to date with the latest treatment advances for optimizing patient care? Credit available for this activity expires: 3/11/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

42 min listen

OncoChallenge in Locally Advanced Head and Neck Cancer: Exploring New Directions: Do you know the optimal management of your patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)? Credit available for this activity expires: 3/18/2025 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

59 min listen

Updates in Breast Cancer From San Antonio 2023: Practice-Changing Data and Clinical Implications: Are you up to date on the latest clinical trial and real-world data in breast cancer and how this impacts individualization of care? Credit available for this activity expires: 1/16/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

31 min listen

Clinical Context of the Consensus: A Review of the Latest Recommendations for Waldenström Macroglobulinemia: Did you know that the latest guidelines for Waldenström macroglobulinemia now encompass second-generation Bruton tyrosine kinase inhibitors? Credit available for this activity expires: 10/16/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

34 min listen

Immunoglobulin A Nephropathy -- Targeting Gut Mucosal Immunity to Modify the Course of the Disease: Did you know that immunoglobulin A nephropathy has very recently seen 2 treatments first licensed for its management? Credit available for this activity expires: 6/29/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

26 min listen

Managing Early-Stage Resectable Non-Small Cell Lung Cancer: Through the Eyes of the Patient and the Care Team: How prepared are you to talk about available perioperative immunotherapies for early-stage resectable non-small cell lung cancer (NSCLC) with your patients? Credit available for this activity expires: 6/30/24 Earn Credit / Learning Objectives &... by Keeping Current

36 min listen

Managing Adverse Events of Novel Antibody-Drug Conjugates in Breast Cancer: Do you know the best practice strategies for preventing and managing adverse events with antibody-drug conjugates (ADCs) in breast cancer? Credit available for this activity expires: 6/27/2024 ... by Keeping Current

19 min listen

The Expanding Role of Mutation Testing in Advanced Gastrointestinal Stromal Tumor: From Biology to Therapy Rationale: Did you know that mutational testing helps guide treatment selection in gastrointestinal stromal tumor (GIST)? Listen to learn more! Credit available for this activity expires: 2/9/2025 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

33 min listen

Navigating the Patient Journey for LA SCCHN: A Look at Treatments for Today and Tomorrow: Do you know the best management for your patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)? Credit available for this activity expires: 10/19/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

55 min listen

Optimizing Treatment Selection in Immune Thrombocytopenia: A Patient Case Discussion: Did you know that there is a tendency among clinicians to overuse corticosteroids in the management of immune thrombocytopenia (ITP)? Credit available for this activity expires: 6/26/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

34 min listen

Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast Cancer: Do you know how to personalize treatment for your patients with metastatic breast cancer (mBC)? How can you incorporate emerging treatment strategies? Credit available for this activity expires: 6/12/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

35 min listen

The Science of Janus Kinase Inhibitors Across Immunologic Diseases: Do you know how to integrate the current evidence about Janus kinase (JAK) inhibitors? Credit available for this activity expires: 2/28/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

35 min listen

6 Practical Steps to Integrating Long-Acting Injectables for HIV Prevention and Treatment: What strategies can facilitate the implementation of long-acting injectables (LAIs) in the clinical setting to optimize patient care? Credit available for this activity expires: 3/13/2025 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

36 min listen

Expert Insights Into the Biosafety of Oncolytic Immunotherapies and Their Combination With Immune Checkpoint Inhibitors: Do you know how the biosafety risks of oncolytic immunotherapies and their combination with immune checkpoint inhibitors can be mitigated? Credit available for this activity expires: 6/22/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

30 min listen

Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma: Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer? Credit available for this activity expires: 3/29/25 Earn Credit / Learning Objectives... by Keeping Current CME

29 min listen

Early-Stage Resectable NSCLC: A Shifting Landscape With Targeted Therapies and Immunotherapy: The perioperative therapeutic landscape for early-stage resectable NSCLC is advancing rapidly. Are you up to date? Credit available for this activity expires: 22/11/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

49 min listen

Which Endpoints Matter Most in Transthyretin Amyloid Cardiomyopathy Trials? Are We Comparing Apples to Apples?: Do you know how to interpret the results of recent phase 3 clinical trials in patients with transthyretin amyloid cardiomyopathy (ATTR-CM)? Credit available for this activity expires: 3/22/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

16 min listen

Dengue Prevention: Integrating Vaccination Into Comprehensive Control Strategies Across Populations: Do you know the priorities for implementing a successful dengue vaccination strategy? Credit available for this activity expires: 5/19/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

38 min listen

HER2-Positive Metastatic Colorectal Cancer: Unraveling Game-Changing Treatment Approaches: Listen to the experts as they share the latest findings on HER2-directed therapies in the treatment of HER2-positive metastatic colorectal cancer (mCRC). Credit available for this activity expires: 2/28/2025 Earn Credit / Learning... by Keeping Current

36 min listen

Taking Control of Fertility With Personalized Insights: Leveling the Fertility Care Continuum: Did you know rates of infertility are rising? Learn how clinicians can engage patients in conception counseling. Credit available for this activity expires: 07/03/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

36 min listen

Evolving Paradigms of Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates: Are you up to date on the latest clinical trial data on antibody-drug conjugates (ADCs) in hormone receptor (HR)-positive advanced breast cancer? Credit available for this activity expires: 11/20/23 Earn Credit / Learning Objectives &... by Keeping Current

71 min listen

Clinical Spotlight: Harnessing the Power of Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Antibody-drug conjugates are revolutionizing the therapeutic landscape for NSCLC. Are you up to date? Credit available for this activity expires: 1/24/2025 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

38 min listen

Discover this podcast and so much more

Metastatic Melanoma: Incorporating Lymphocyte-Activation Gene 3 Inhibitors Into the Treatment Paradigm

Metastatic Melanoma: Incorporating Lymphocyte-Activation Gene 3 Inhibitors Into the Treatment Paradigm

Description

Titles in the series (100)

More Episodes from Keeping Current CME

Related podcast episodes